New initiative positions Africa\'s public and private development banks as strategic enablers of clean energy access
HONG KONG,Feb. 27,2025-- Following its successful launch in 2024,Super Terminal Expo is set for its return to AsiaWorld-Expo,Hong Kong,from 4-6 November 2025,embodying a broader focus that now spans m
The 3rd China-ASEAN Innovation and Entrepreneurship Competition is now recruiting
KUALA LUMPUR,Malaysia,Feb. 27,2025-- In collaboration with ASEAN Secretariat,the Ministry of Science and Technology of the People\'s Republic of China will host the 3rdChina-ASEAN Innovation and Entre
AIR INDIA IMPROVES CONNECTIVITY FROM MALAYSIA TO EUROPE VIA INDIA
Air India offers enhanced connectivity from the Malaysia to European destinations such as London Heathrow,Frankfurt,Paris,Amsterdam via India,reducing connection times to around 2.5 hours
Tuniu to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 14, 2025
NANJING,China,Feb. 26,2025-- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"),a leading online leisure travel company in China,today announced that it plans to release it
Global Sourcing Fair Vietnam 2025 - More Suppliers, More Opportunities, More Business
HO CHI MINH CITY,Vietnam,Feb. 26,2025-- Organized by Global Sources,the GlobalSourcing Fair Vietnam 2025 returns for its third edition from April 24 to 26 at the Saigon Exhibition and Convention Cente
VICTORIA,Seychelles,Feb. 26,2025-- SquaredFinancial,a global leader in fintech and trading solutions,is proud to announce another year of record-breaking performance,marked by significant profit grow
16 Years of PT SMI, Driving Growth Through Impactful Development
JAKARTA,Indonesia,Feb. 26,2025-- PT Sarana Multi Infrastruktur ("Persero") ("PT SMI") continues to maintain its existence to provide impacts through support for equitable developme
HONG KONG,Feb. 25,2025-- On 21 February,Guo Guangchang,Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025,stating that private enterprises are
SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the